Mendus AB (CHIX:IMMUS) Volatility: N/A% (As of Jul. 06, 2026)


CHIX:IMMUS Mendus AB CHIX:IMMUS
27 GF Score
Price kr32.70
! 2 Warning Signs
View Full Analysis

What is Mendus AB Volatility?

Mendus AB CHIX:IMMUS 27 Volatility is N/A% as of Jul. 06, 2026. GuruFocus rates CHIX:IMMUS with a GF Score™ of 27/100. The stock has 2 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

Mendus AB does not have enough data to calculate Volatility.

Mendus AB  (CHIX:IMMUs) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Mendus AB Volatility Related Terms

CHIX:IMMUS vs VRTX, REGN, ALNY: Volatility Comparison

For the Biotechnology subindustry, Mendus AB's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mendus AB Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mendus AB's Volatility distribution charts can be found below:

* The bar in red indicates where Mendus AB's Volatility falls into.


CHIX:IMMUS
27GF Score
Mendus AB CHIX:IMMUS
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mendus AB  (CHIX:IMMUs) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of N/A% mean?
Mendus AB (CHIX:IMMUS) has a Volatility of N/A% as of Jul. 06, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Mendus AB and its competitors.
Is Mendus AB's Volatility too high?
Mendus AB's current Volatility is N/A%. Overall, Mendus AB has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Mendus AB's Volatility compare to VRTX and REGN?
Mendus AB's Volatility of N/A% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Mendus AB and its competitors. Mendus AB's current Volatility is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mendus AB stock overvalued right now?
Mendus AB (CHIX:IMMUS) has a current Volatility of N/A%. The current Volatility is N/A%. Mendus AB's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Mendus AB (CHIX:IMMUS), the current Volatility is N/A% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mendus AB Business Description

Other Exchanges IMMU:Sweden1YG0:Germany
Address Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals. The company's Pipeline includes: Vididencel, and Ilixadencel.
27GF Score

Get the complete analysis for CHIX:IMMUS

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr32.70
Price